Improving patient recruitment to multicentre clinical trials: The case for employing a data manager in a district general hospital-based oncology centre

被引:6
作者
Street, A [1 ]
Strong, J
Karp, S
机构
[1] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England
[2] Pharmax Ltd, Bexley, England
[3] N Middlesex Hosp, Clin Oncol Ctr, London, England
关键词
clinical trials; data manager; oncology; patient recruitment; research and development funding;
D O I
10.1007/s001740170111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One of the most frequently cited reasons for poor recruitment to multicentre randomized clinical trials is the additional workload placed on clinical staff. We report the effect on patient recruitment of employing a data manager to support clinical staff in an English district general hospital (DGH). In addition, we explore the effect data managers have on the quality of data collected, proxied by the number of queries arising with the trial organizers. We estimate that the cost of employing a data manager on a full-time basis is pound 502 per patient recruited but may amount to pound 326 if the appointment is part-time. Data quality is high when full responsibility lies with a data manager but falls when responsibility is shared. Whether the costs of employing a data manager to recruit patients from a DGH are worth incurring depends on the value placed on the speed at which multicentre trials can be completed, how important it is to broaden the research base beyond the traditional setting of teaching hospitals, and the amount of evaluative data required.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 26 条
[1]   ONCOLOGISTS RELUCTANCE TO ACCRUE PATIENTS ONTO CLINICAL-TRIALS - AN ILLINOIS CANCER CENTER STUDY [J].
BENSON, AB ;
PREGLER, JP ;
BEAN, JA ;
RADEMAKER, AW ;
ESHLER, B ;
ANDERSON, K .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) :2067-2075
[2]  
Culyer A., 1994, SUPPORTING RES DEV N
[3]   BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].
DEVITA, VT .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529
[4]   FUNDING RESEARCH-AND-DEVELOPMENT IN THE NHS [J].
DRUMMOND, MF ;
CRUMP, BJ ;
LITTLE, VA .
LANCET, 1992, 339 (8787) :230-231
[5]   ON CLINICAL-TRIAL PARTICIPATION [J].
FISHER, B .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) :1927-1930
[6]  
Foley J F, 1991, J Cancer Educ, V6, P165
[7]  
FRIEDMAN MA, 1990, CANCER, V65, P2376, DOI 10.1002/1097-0142(19900515)65:10+<2376::AID-CNCR2820651504>3.0.CO
[8]  
2-A
[9]   ACCRUAL TO CANCER CLINICAL-TRIALS - DIRECTIONS FROM THE RESEARCH LITERATURE [J].
GOTAY, CC .
SOCIAL SCIENCE & MEDICINE, 1991, 33 (05) :569-577
[10]   Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studies [J].
Hancock, BW ;
Aitken, M ;
Radstone, C ;
Hudson, GV .
BRITISH MEDICAL JOURNAL, 1997, 314 (7073) :36-37